Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Distributions	Accumulated Deficit
Shares outstanding, beginning balance (in shares) at Dec. 31, 2019		8,851,759
Stockholders' equity, beginning balance at Dec. 31, 2019	$ 82,296,472	$ 88,518	$ 87,973,949	$ (2,369,592)	$ (3,396,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,304,712
Issuance of common stock	12,976,744	$ 13,047	12,963,697
Distributions to investors	(1,183,119)			(1,183,119)
Net loss	(790,050)				(790,050)
Shares outstanding, ending balance (in shares) at Mar. 31, 2020		10,156,471
Stockholders' equity, ending balance at Mar. 31, 2020	$ 93,300,047	$ 101,565	100,937,646	(3,552,711)	(4,186,453)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2020	12,232,289	12,232,289
Stockholders' equity, beginning balance at Dec. 31, 2020	$ 102,083,726	$ 122,323	121,676,787	(7,767,642)	(11,947,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share based compensation	45,000		45,000
Distributions to investors	(1,511,005)			(1,511,005)
Net loss	$ (3,009,989)				(3,009,989)
Shares outstanding, ending balance (in shares) at Mar. 31, 2021	12,232,289	12,232,289
Stockholders' equity, ending balance at Mar. 31, 2021	$ 97,607,732	$ 122,323	$ 121,721,787	$ (9,278,647)	$ (14,957,731)